Oncogenic Notch signaling in T-cell and B-cell lymphoproliferative disorders

MY Chiang, V Radojcic, I Maillard - Current opinion in hematology, 2016 - journals.lww.com
Oncogenic Notch signaling in T-cell and B-cell lymphoprolife... : Current Opinion in Hematology
Oncogenic Notch signaling in T-cell and B-cell lymphoproliferative disorders : Current Opinion …

Targeting CK2-driven non-oncogene addiction in B-cell tumors

E Mandato, S Manni, F Zaffino, G Semenzato, F Piazza - Oncogene, 2016 - nature.com
Genetic mutations of oncogenes often underlie deranged cell growth and altered
differentiation pathways leading to malignant transformation of B-lymphocytes. However …

[HTML][HTML] WDR5 high expression and its effect on tumorigenesis in leukemia

Z Ge, EJ Song, YI Kawasawa, J Li, S Dovat, C Song - Oncotarget, 2016 - ncbi.nlm.nih.gov
Abstract WD repeat domain 5 (WDR5) plays an important role in various biological functions
through the epigenetic regulation of gene transcription. However, the oncogenic effect of …

Transcriptional regulation of JARID1B/KDM5B histone demethylase by ikaros, histone deacetylase 1 (HDAC1), and casein kinase 2 (CK2) in B-cell acute …

H Wang, C Song, Y Ding, X Pan, Z Ge, BH Tan… - Journal of Biological …, 2016 - ASBMB
Impaired function of the Ikaros (IKZF1) protein is associated with the development of high-
risk B-cell precursor acute lymphoblastic leukemia (B-ALL). The mechanisms of Ikaros tumor …

Epigenetic regulation of gene expression by Ikaros, HDAC1 and Casein Kinase II in leukemia

C Song, X Pan, Z Ge, C Gowda, Y Ding, H Li, Z Li… - Leukemia, 2016 - nature.com
IKZF1 (Ikaros) encodes a DNA-binding protein that acts as a master regulatory of
hematopoiesis and a tumor suppressor in acute lymphoblastic leukemia (ALL). 1-4 The …

[HTML][HTML] High CRLF2 expression associates with IKZF1 dysfunction in adult acute lymphoblastic leukemia without CRLF2 rearrangement

Z Ge, Y Gu, G Zhao, J Li, B Chen, Q Han, X Guo, J Liu… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Overexpression of cytokine receptor-like factor 2 (CRLF2) due to chromosomal
rearrangement has been observed in acute lymphoblastic leukemia (ALL) and reported to …

[HTML][HTML] Co-existence of IL7R high and SH2B3 low expression distinguishes a novel high-risk acute lymphoblastic leukemia with Ikaros dysfunction

Z Ge, Y Gu, L Xiao, Q Han, J Li, B Chen, J Yu… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Acute lymphoblastic leukemia (ALL) remains the leading cause of cancer-related death in
children and young adults. Compared to ALL in children, adult ALL has a much lower cure …

[HTML][HTML] A novel xenograft model to study the role of TSLP-induced CRLF2 signals in normal and malignant human B lymphopoiesis

OL Francis, TAM Milford, SR Martinez, I Baez… - …, 2016 - ncbi.nlm.nih.gov
Thymic stromal lymphopoietin (TSLP) stimulates in vitro proliferation of human fetal B-cell
precursors. However, its in vivo role during normal human B lymphopoiesis is unknown …

Targeting High Dynamin-2 (DNM2) Expression by Restoring Ikaros Function in Acute Lymphoblastic Leukemia

Z Ge, Y Gu, Q Han, G Zhao, M Li, J Li, B Chen, T Sun… - Scientific reports, 2016 - nature.com
Abstract Dynamin-2 (DNM2) is a GTPase essential for intracellular vesicle formation and
trafficking, cytokinesis and receptor endocytosis. Mutations in DNM2 are common in early T …

[HTML][HTML] Optimal interleukin-7 receptor-mediated signaling, cell cycle progression and viability of T-cell acute lymphoblastic leukemia cells rely on casein kinase 2 …

A Melão, M Spit, BA Cardoso, JT Barata - Haematologica, 2016 - ncbi.nlm.nih.gov
Abstract Interleukin-7 and interleukin-7 receptor are essential for normal T-cell development
and homeostasis, whereas excessive interleukin-7/interleukin-7 receptor-mediated …